Targeting ATF5, CEBPB, and CEBPD with Cell-Penetrating Dpep Sensitizes Tumor Cells to NK-92MI Cell Cytotoxicity
Cells · 2025
DOI: 10.3390/cells14090667 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Qing Zhou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY 10032, …. Hauptthemen laut MEDLINE: Killer Cells, Natural, Cell-Penetrating Peptides, CCAAT-Enhancer-Binding Protein-beta, Activating Transcription Factors. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NCI NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Natural killer (NK) cells are an important innate defense against malignancies, and exogenous sources of NK cells have been developed as anti-cancer agents. Nevertheless, the apparent limitations of NK cells in clearing cancers have suggested that their efficacy might be augmented by combination with other treatments. We have developed cell-penetrating peptides that target the transcription factors ATF5, CEBPB, and CEBPD and that promote apoptotic cancer cell death both in vitro and in vivo without apparent toxicity to non-transformed cells. We report here that one such peptide, Dpep, significantly sensitizes a variety of tumor cell types to the cytotoxic activity of the NK cell line, NK-92MI. Such sensitization requires pre-exposure of tumor cells to Dpep and does not appear due to effects of Dpep on NK cells themselves. Our findings suggest that Dpep acts in this context to lower the apoptotic threshold of tumor cells to NK cell toxicity. Additionally, while Dpep pre-treatment does not prevent tumor cells from causing NK cell “inactivation”, it sensitizes cancer cells to repeated rounds of exposure to fresh NK cells. These findings thus indicate that Dpep pre-treatment is an effective strategy to sensitize cancer cells to the cytotoxic actions of NK cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY 10032, USA.
ORCID-Profile: Lloyd A Greene
Förderung
- NIH HHS
- NCI NIH HHS
- NINDS NIH HHS
- NIH
- Herbert Irving Comprehensive Cancer Center Flow Cytome try Shared Resources
Zitieren
APA
Zhou, Q., Siegelin, M. D., & Greene, L. A. (2025). Targeting ATF5, CEBPB, and CEBPD with Cell-Penetrating Dpep Sensitizes Tumor Cells to NK-92MI Cell Cytotoxicity. Cells. https://doi.org/10.3390/cells14090667
Vancouver
Zhou Q, Siegelin MD, Greene LA. Targeting ATF5, CEBPB, and CEBPD with Cell-Penetrating Dpep Sensitizes Tumor Cells to NK-92MI Cell Cytotoxicity. Cells. 2025. doi:10.3390/cells14090667
BibTeX
@article{Zhou2025,
author = {Zhou, Qing and Siegelin, Markus D and Greene, Lloyd A},
title = {Targeting ATF5, CEBPB, and CEBPD with Cell-Penetrating Dpep Sensitizes Tumor Cells to NK-92MI Cell Cytotoxicity},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14090667}
}
EUVIMED